Clinical trial
Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative…
NCT00197483 · Hamamatsu University, Other · Suspended
Key facts
| NCT number | NCT00197483 |
|---|---|
| Title | Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia |
| Official title | Effective Adjunctive Use of Pergolide With Risperidone for Cognitive Impairment and Negative Symptoms in Schizophrenia |
| Lead sponsor | Hamamatsu University, Other |
| Status | Suspended |
| Study type | Observational |
| Conditions | Schizophrenia, Negative Symptoms, Cognitive Impairments |
| Intervention type | Drug |
| Interventions | Pergolide (drug) |
| Enrollment | 20 |
| Start date | Mar 1, 2003 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 20, 2005 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: